Previous 10 | Next 10 |
2023-11-07 16:00:27 ET Neuronetics, Inc. (STIM) Q3 2023 Earnings Conference Call November 07, 2023, 08:30 AM ET Company Participants Mark Klausner - ICR Westwicke Keith Sullivan - President and CEO Steve Furlong - CFO Conference Call Participants Marg...
2023-11-07 07:35:05 ET More on Neuronetics Neuronetics: Large Losses May Be Repelling Investors Neuronetics draws down remaining $22.5M under credit facility Seeking Alpha’s Quant Rating on Neuronetics Historical earnings data for Neuronetics F...
MALVERN, Pa., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”) a commercial stage medical technology company with a strategic vision of transforming the lives of patients whenever and wherever they need help, with...
Weyco Group Inc. (WEYS) is expected to report for Q1 2024 Gladstone Land Corporation (LAND) is expected to report $0.16 for Q3 2023 PlayAGS Inc. (AGS) is expected to report $0.01 for Q3 2023 Ardmore Shipping Corporation (ASC) is expected to report $0.43 for Q3 2023 Sage Therapeuti...
Neuronetics Inc. (STIM) is expected to report $-0.3 for Q3 2023
MALVERN, Pa., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced that it pla...
MALVERN, Pa., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced today that clinical findings from ...
2023-10-03 11:56:14 ET More on Neuronetics Neuronetics: Large Losses May Be Repelling Investors Neuronetics, Inc. (STIM) Q2 2023 Earnings Call Transcript Neuronetics, Inc. 2023 Q2 - Results - Earnings Call Presentation Seeking Alpha’s Quant Rating on N...
MALVERN, Pa., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company with a strategic vision of transforming the lives of patients whenever and wherever they need help with the best neurohealth therapies in the world, announced today that...
MALVERN, Pa., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, in recognition of National Suicide Preventi...
News, Short Squeeze, Breakout and More Instantly...
MALVERN, Pa., July 22, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced that Aetna has updated its TMS (tr...
MALVERN, Pa., July 11, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced that California Medicaid (Medi-Cal...